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1. Introduction
Provision of citizens’ work-
ing ability by maintaining their 
health through the availability of 
effective medicines is a priority 
for scientists and practitioners of 
pharmacy.
The development of a medic-
inal product is a very complex, 
multifactorial and multistage 
process. The ultimate goal of this 
process is to obtain a quality 
product. Information obtained 
during the research in the course 
of pharmaceutical development 
can serve as a basis for man-
aging the risks to quality. It is 
important to understand that 
quality can not be only checked 
in preparations – quality should 
be considered in the design.
Pharmaceutical development 
of a new drug is based on such 
components as development of 
the methodological approach, 
medical and biological require-
ments for medicines, pharma-
co-technological tests, marketing 
analysis of the modern pharma-
ceutical market, etc. [1].
The aim of the work is to 
develop and justify the compo-
sition of a new pharmaceutical 
preparation in the form of hard 
gelatin capsules based on a dry 
extract of hop cones for use in 
gastroenterological practice.
2. Methods
A search and generalization of 
the data of information and scien-
tific primary sources concerning 
preparations based on the Humu-
lus lupulus and the fields of their 
application have been performed. 
As information sources were used 
data from the State Register of 
Medicines of Ukraine, the direc-
tory “Compendium”, phytother-
apeutic reference books, Internet 
resources. The modern marketing method of SWOT-analysis, 
which allows determining the approaches to improving the com-
petitive potential of a product, clarifying the main directions 
in the formation of a marketing program for creating and 
launching a new drug and a loyalty program has also been used.
3. Results
According to the purpose of this work, a research method-
ology, presented in the form of a flowchart in Fig. 1 has been 
developed. 
The effectiveness of drugs of both local and general action 
depends on the influence of a whole set of interrelated factors, 
the most important of which is the ability of the active in-
gredient to optimally affect the 
damaged target tissues, as well as 
the characteristics of the dosage 
form auxiliaries that provide this 
capability. That is why, when cre-
ating new and improving exist-
ing medicines, the first task is to 
find an effective and safe active 
substance.
Common Hop, or Hop (lat. 
Húmulus lúpulus) – a species of 
herbaceous perennial plants of 
genus Humulus family Cannaba-
ceae. In natural conditions hops 
inhabit the territories of North 
America and Canada [2]. 
Hops cones (female inflores-
cences) were originally used for 
the preparation of beer, berg and 
honey, later they were used in 
bakery and medicine.
Hop is a valuable medicinal 
plant. The main substances that 
determine the biological activ-
ity of hop cones are bitterness, 
phenolic compounds and essen-
tial oil. In addition, hop cones 
contain asparagine, triterpene 
compounds (hopanone and hy-
droxy-hopanone), vitamins (ru-
tin, C, E, B1, B3, B6, H and 
PP). Medicines from hop cones 
have versatile pharmacological 
properties – soothing, analgesic, 
hypnotic, anti-inf lammatory, 
capillary-strengthening, antiul-
cer [3].
The positive effect of galen-
ic medicines of hop on metab-
olism, especially on the regu-
lation of fat, mineral and water 
metabolism has been noted. 
The neurotropic effect of ga-
lenic preparations from cones 
of hop is associated with the 
presence of lupulin, which has 
a calming effect on the central 
nervous system. Anti-inf lam-
matory, analgesic, bactericidal 
and antiallergic properties of 
herbal preparations of the plant determine their therapeutic 
effectiveness in diseases of the skin and mucous membranes, 
accompanied by inf lammatory lesions, allergic manifesta-
tions, itching and other symptoms [4, 5].
Hops are widely used in folk medicine. Infusion or decoc-
tion of hop cones intensifies digestion, they are recommend-
ed in kidney and liver diseases, gastritis, dropsy, jaundice, 
neuralgia, insomnia [6].
Bitter acids of hops possess antibacterial and antifungal 
activity. In particular, the activity of humulone and lupulone 
in relation to gram – positive bacteria has been established. 
Antiviral action of iso-α-acids against DNA and RNA viruses 
was also established [7].
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The aim of the work was to justify the feasibility of developing 
a new drug with a dry extract of hop cones in the form of hard 
gelatin capsules for the treatment of gastrointestinal diseases.
Methods. In order to study the range of medicines based on 
hop cones on the pharmaceutical market of Ukraine, a mar-
keting analysis of registered drugs has been conducted. The 
marketing analysis was carried out using the information of re-
trieval system "Drugs" by "Morion" LLC and the State Register 
of Medicines of Ukraine, which allows quickly tracking chang-
es in the structure of offers. To systematize the main character-
istics of the studied drug of hop cones, to assess its strengths 
and weaknesses, opportunities and threats, a modern market-
ing method – SWOT-analysis has been used. In the process 
of research, methods of system analysis, monitoring, logical 
generalization, grouping of marketing research, etc. were used. 
Results. The methodology of research has been developed and 
justified. The main types of pharmacological activity of extracts 
from hop raw materials have been reviewed. A comprehensive 
study of the drug from hop cones using the SWOT-analysis 
method has allowed analyzing its strengths and weaknesses, 
which can contribute to or hamper the progress and consoli-
dation of this drug in a certain market segment. It was revealed 
that the strengths of the drug are much greater than the weak-
nesses, and this speaks in favor of its competitiveness in the 
pharmaceutical market of Ukraine.
The discussion of the results. The medical and marketing expe-
diency of developing a new medicinal preparation with a dry 
extract of hop cones in the form of capsules for use in gastro-
enterology have been proved.
Keywords: dry extract of hop cones, hard gelatin capsules, 
methodology, marketing methods of analysis, development, 
SWOT-analysis, GI diseases.
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The therapeutic effect of hops in diseases of the 
gastrointestinal tract is caused by bitter compounds 
that are part of the lupulin. Water infusions from 
mature hop inflorescences are prescribed to im-
prove appetite, digestion in chronic hyposecretory 
gastritis, gastroenteritis, diseases of the gallbladder 
and liver. In patients with chronic gastritis with 
secretory deficiency, the use of a decoction of hop 
cones (1:5) promotes strengthening of gastric secre-
tion and evacuation function of the stomach [8, 9].
An analysis of the modern pharmaceutical mar-
ket has been conducted which has shown that ex-
tracts from the raw material of hop are included in 
the composition of the drugs presented in Table 1.
A similar composition and indications for use 
have some preparations produced in Germany – 
dragee “Ardeysedon”, “Nervenruh forte”, tablets “Seda 
Kneipp”; in Hungary – tablets “Hovaletten”; in Slove-
nia – drops “Valosedan”. Also, the data on the use of 
substances from hops in the production of many food 
supplements with a recommendation for use as seda-
tives and hypnotics have been found [10, 11].
As can be seen from the results given in Table 1, 
pharmaceuticals with hops are used in the treatment 
of insomnia and nervous disorders, as well as in 
diseases of certain parts of the gastrointestinal tract.
At the same time, data from literature sources 
and studies conducted at the departments of phar-
macognosy and physiology with the fundamentals 
of anatomy of the National University of Pharmacy 
(Kharkov, Ukraine), indicate the presence of an-
ti-inflammatory and reparative activity in the dry 
extract of hop cones. 
Choice of API 






Development of model 
composition of the drug 
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of incapsulation masses model 
series
Study of incapsulation 
process
Development of hard gelatin 
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Quality control of obtained 
capsules
Fig. 1. The research methodology for the development of a drug in the form 
of hard gelatin capsules
Table 1
Nomenclature of preparations based on common hop
Name of medicinal product The form of release, manufacturer Type of substance from common hop Pharmacologic effect
Cones of common hop Blend PJSC "Lektravy", Ukraine Medicinal plant raw materials Sedative, anti-inflammatory, reparative
Valocordin Drops; Krewel Meuselbach, Germany Essential oil Sedative, hypnotic, spasmolytic
Corvaldin Drops; PJSC Farmak, Ukraine Essential oil Sedative, hypnotic, spasmolytic
Herbion Drops; KRKA, Slovenia Water-alcohol extract Sedative, hypnotic
Detoxifit Blend SIC "Aim" Ltd, Ukraine Medicinal plant raw materials Cholagogue, antispasmodic, anti-inflammato-ry, capillaroprotective and decongestant
Calming blend Blend PJSC "Lektravy", Ukraine Medicinal plant raw materials Sedative
Sedative blend number 2 Blend CJSC PF "Viola", Ukraine Medicinal plant raw materials Sedative
Nervoflux Instant tea; Aventis/Rhone-Poulenc Rorer, France Dry extract Sedative, hypnotic
Novo-Passit Solution, tablets; Galena, Czech Republic Extract Sedative, anxiolytic
Sanason Tablets; Lek, Slovenia Extract Sedative, hypnotic
Lekson Solution SE «GNTSLS», Ukraine Water-alcohol extraction Sedative, hypnotic
Sedavit Tablets, solution; Arterium  Corporation, Ukraine Extract Anxiolytic
Urolesan Capsules; Drops; Arterium  Corporation, Ukraine Extract Antibacterial, choleretic
Trivalumen Capsules; PJSC SPC  "Borschagovsky CPP", Ukraine Extract
Sedative, anti-inflammatory, diuretic,  
choleretic
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Therefore, we consider it advisable to conduct research on 
the development of the composition and technology of a solid 
dosage form for the treatment of pathologies caused by inflam-
mation in the internal organs, for example gastritis or gastric 
ulcer [4, 6].
According to the developed methodology (Fig. 1), a strate-
gic approach to creating new medicines as vital goods requires 
marketing justification for their implementation. Considerable 
attention and efforts are given to the study of the macro- and 
microenvironment of the medicines’ target market segment, 
determination of the social and medical need for a new drug, its 
competitiveness, innovation, economic efficiency and commer-
cial attractiveness.
It was previously established that hop cones are used in of-
ficial and folk medicine, in homeopathy, cosmetology and have 
sedative, antispasmodic, analgesic, anti-inflammatory, antiul-
cer, antiallergic, regenerative, bactericidal, fungicidal, diuretic 
action in the forms of tincture, oil, infusion, extract, blend, 
capsules, dragee, ointments [12]. 
In order to systematize the main characteristics of the drug 
from hop cones, to assess strengths, weaknesses, opportunities 
and threats, the modern marketing method of SWOT-analysis 
has been used. The results are given in Table 2.
Thus, conducted marketing and medical studies confirm 
the advisability of developing a new drug with a dry extract of 
hop cones in the form of complex action capsules for the treat-
ment and prophylaxis of patients with functional disorders of 
the gastrointestinal tract.
4. Discussion
The methodology for the creation of hard gelatin capsules for 
use in gastroenterology has been substantiated. It includes such 
basic stages of research as goal formation, marketing, technolog-
ical, physico-chemical, biopharmaceutical and biological studies.
The properties of the active pharmaceutical ingredient, 
namely the dry extract of hop cones, which is selected as the 
object of the study in the development of a medicament for the 
treatment of gastrointestinal diseases, have been considered.
Marketing and medico-sociological studies were conducted, 
which confirmed the advisability of developing a new medicinal 
product with a dry extract of hop cones in the form of capsules 
for the treatment and prophylaxis of patients with functional 
disorders of the gastrointestinal tract.
A comprehensive study of the drug using the SWOT-anal-
ysis has allowed analyzing its strengths and weaknesses, which 
can contribute to or hamper the progress and consolidation of 
this drug in a certain market segment. It was revealed that the 
strengths of the drug are much greater than the weaknesses, and 
this speaks of its competitiveness in the pharmaceutical market.
The results obtained in the study might be used in the devel-
opment and industrial implementation of hard gelatin capsules 
for GIT diseases treatment.
Table 2
SWOT-analysis of medicines from dry hop cones extract 
Strengths Weaknesses 
– long-term successful experience of using the remedies from hop cones 
in folk medicine; 
– a wide range of pharmacological actions; 
– positive effect of the drug from medicinal plant material; 
– widely used in other countries; 
– used as a food additive; 
– are included in combined preparations, dietary supplements of domese-
tic and foreign production; 
– absence of capsules with dry extract of hop cones; 
– variety of dosage forms; 
– wide range of prices from different manufacturers
− side effects: 
– light dizziness;  
– vomiting;  
– abdominal pain;  
– headache; 
– feeling tired and shattered; 
– dry mouth
Opportunities Threats 
– wide application for the prevention and treatment of diseases in varir-
ous categories of patients; 
– application in combination with other agents; 
– significant expansion of the market segment; 
– expansion of indications for the use of the drug; 
– increase in the market share of the drug; 
– the possibility of applying a wide range of prices; 
– strengthening of information and promotional activities among target 
audiences; 
– carrying out of actions on increase of involvement of experts to prepap-
rations from hop cones; 
– increase in the number of offers on the market
– aggressive advertising of antiulcer drugs; 
– introduction of similar pharmacological action vegetable preparations 
on the market; 
– introduction of the new generation anti-ulcer drugs on the market; 
– conservatism of doctors; 
– “Price wars” of competitors; 
– the inclusion of competing drugs in the forms of patients treatment
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